Jeffrey B Kopp

Title: The Innovations of Jeffrey B Kopp

Introduction

Jeffrey B Kopp is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of medical research, particularly in the areas of renal disease and HIV-1 detection. With a total of 2 patents, Kopp's work has the potential to impact many lives.

Latest Patents

Kopp's latest patents include methods for determining the genetic predisposition of a human subject to developing renal disease. This includes conditions such as focal segmental glomerulosclerosis (FSGS) or end-stage kidney disease. The methods utilize the detection of haplotype blocks comprising tag single nucleotide polymorphisms (SNPs) in a non-coding region of the MYH9 gene. Additionally, he has developed monoclonal antibodies to HIV-1 Vpr, along with hybridoma cell lines that produce these antibodies. These innovations provide methods for detecting HIV-1 infection, showcasing Kopp's versatility in addressing critical health issues.

Career Highlights

Kopp works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization allows him to contribute to public health initiatives and research advancements.

Collaborations

Some of Kopp's notable coworkers include Cheryl Winkler and George E Nelson. Their collaborative efforts in research have likely enhanced the impact of their innovations.

Conclusion

Jeffrey B Kopp's contributions to medical research through his patents reflect his commitment to improving health outcomes. His work in genetic predisposition to renal disease and HIV-1 detection demonstrates the importance of innovation in addressing public health challenges.